- According to the World Health Organization, health officials are witnessing early signs that the new monkeypox case growth may be waning in Europe and the U.S.
- Public-health experts said they remain cautious about whether the outbreak has peaked as efforts continue to stretch limited vaccine supplies and protect vulnerable individuals.
- “If anything, we need to continue to strongly communicate and educate the public about this pathogen,” said Rodney Rohde, a public-health expert at Texas State University.
- Related: Bavarian Nordic Making All Efforts To Stretch Capacity To Boost Monkeypox Vaccine Supplies.
- According to CDC statistics, at least 46,337 monkeypox cases have been reported in about 90 countries. While Europe was hit hard early on, the U.S. now has roughly one-third of the known cases. The CDC said about 17,000 cases had been reported in the U.S.
- The World Health Organization said monkeypox cases globally declined 21% last week, after a month-long trend of rising infections.
- Some U.S. experts believe cases are starting to decline mainly based on immunity from prior infection and behavior changes as awareness of the disease has grown.
- Photo Jernej Furman from Flickr
Loading...
Loading...
BVNKFBavarian Nordic AS
$37.02-%
BVNRYBavarian Nordic AS
$12.23-0.73%
EJHE-Home Household Service Holdings Ltd
$0.9300-6.06%
GOVXGeovax Labs Inc
$0.5500-2.26%
INOInovio Pharmaceuticals Inc
$2.412.12%
MRNAModerna Inc
$27.23-3.24%
SIGASIGA Technologies Inc
$8.28-0.36%
TNXPTonix Pharmaceuticals Holding Corp
$18.894.60%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
